The National Vaccine Plan Process - Update

October 22, 2007

Raymond A. Strikas, MDNational Vaccine Program Office

Department of Health and Human Services

Planning Process Summary• Process to date

– March 20 and June 5, 2007 interagency meetings– Discussions with Assistant Secretary for Health

• One-on-one discussions with agencies, Departments: CDC, FDA, NIH, HRSA, AHRQ, ASPR, USAID, DoD

• Priorities’ development by agencies, Departments

Four Categories (1994 Plan’s Goals)

• Develop new and improved vaccines

• Ensure optimal safety and effectiveness of vaccines and immunization

• Better educate the public and members of the health professions on the benefits and risks of immunizations

• Achieve better use of existing vaccines to prevent disease, disability, and death

Top Ten Priority Areas(really 11)

1. Vaccine research and development: Enhance

2. Adult Immunization: Improve immunization rates for vaccines recommended for widespread use among adults to achieve coverage targets

3. Adolescent Immunization: Achieve 90% coverage for ACIP recommended vaccines

4. Barriers to vaccination: Reduce or eliminate financial barriers to access for recommended vaccines for all populations

5. Childhood vaccination: Maintain high coverage6. New Vaccines: Develop, such as

1. HIV2. TB3. Malaria

Top Ten Priority Areas(really 11) - continued

7. Vaccine Supply: Enhance security

8. Vaccine Safety: Enhance current infrastructure to better monitor adverse events and determine risk factors and mechanisms for adverse events

9. Compensation: Assure the National Vaccine Injury Program continues to compensate persons truly injured by vaccines

10. Global Health: Advance global disease reduction and eradication goals

11. Surveillance: Assure systems are in place to adequately monitor the epidemiology of vaccine-preventable diseases and immunization coverage

Priorities

• Received from many, but not all, agencies and offices.

• Limited prioritization within lists offered

• Few milestones and dates for achievement listed

• Differences of emphasis to be resolved

Our Tasks for the Priorities• Review categories, areas, issues in particular

– Are all listed appropriate?– What is missing?

• Propose actions as appropriate (to be completed by lead, contributing agencies)

• Review proposed lead and contributing agencies

• To follow:– Prioritization within areas by lead agencies– 2012-15 milestones – NVAC review, beginning with Vaccine Supply and Development

subcommittee today

Stakeholder Involvement Approach

• Complete priorities’ table

• Review with National Vaccine Advisory Committee

• Engage other expert stakeholders through Institute of Medicine expert committee (discussion to follow)

• Engage broader groups of stakeholders, including the general public – Focus groups’ trial October 30, 2007– “Deliberation Day” town-hall style meeting(s) to follow